logo
Plus   Neg
Share
Email

JPMorgan Shareholders Marginally Approves Jamie Dimon's Pay Package

JPMorgan Chase & Co (JPM) said that investors holding about 72% of the shares voted in favor of Chief Executive officer James Dimon's pay, just above the 70% threshold that is viewed as a minimum by corporate-governance experts. But, about 93% supported JPMorgan's executive pay in the previous year.

Dimon earned a total of $31 million in 2018, up from $29.5 million the year earlier.

The proxy advisory group Institutional Shareholder Services Inc. didn't object to the amount the bank pays Dimon and other executives. But the proxy advisory group did criticize the bank for not providing enough clarity to shareholders on how it determines the compensation.

All of its directors were elected, and a shareholder proposal that the bank report annually on its global gender pay gap was voted down, the company said.

JPMorgan also declared a quarterly dividend of $0.80 per share. The dividend is payable on July 31, 2019, to stockholders of record at the close of business on July 5, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT